All posts by imreal

Rapid Novor’s Blood Test for Multiple Myeloma Monitoring is CLIA Certified for Clinical Use in the US


Abir Khaled, Multiple Myeloma Senior Research Scientist at Rapid Novor

Abir Khaled, Multiple Myeloma Senior Research Scientist at Rapid Novor

The non-invasive and highly sensitive nature of EasyM™ makes it an ideal assay to assess MRD status as an efficacy endpoint for clinical trials of novel therapeutic drugs.

Rapid Novor Inc., the world’s leader in mass spectrometry (MS)-based antibody protein sequencing, announced today that its diagnostic laboratory obtained the Clinical Laboratory Improvement Amendments (CLIA) certification for their EasyM™ assay as a Laboratory Developed Test (LDT). EasyM™ is the world’s first personalized blood test for Multiple Myeloma to receive such certification. This means clinicians now have access to a simple blood test for highly sensitive measurable residual disease (MRD) monitoring of multiple myeloma.

Multiple myeloma is the second most common form of hematological (blood) cancer with ~175,000 new cases worldwide each year. The presence of MRD is an important prognostic factor for multiple myeloma and typically requires ongoing assessments for detection and monitoring of disease progression. However, current clinical tests for MRD often lack the sensitivity or require the invasive, expensive, and time-intensive practice of bone marrow biopsies – putting physical and financial burden on the patients.

“The CLIA certification for EasyM™ is a major milestone in multiple myeloma MRD testing,” said Dr. Liqiang Yang, Chief Strategy Officer at Rapid Novor. “EasyM™ now provides a much-needed option for patients with multiple myeloma who can benefit from frequent monitoring of their disease especially during the complete remission (CR) stage without invasive bone-marrow aspirates. The non-invasive and highly sensitive nature of EasyM™ makes it an ideal assay to assess MRD status as an efficacy endpoint for clinical trials of novel therapeutic drugs.”

The EasyM™ assay measures the levels of M-protein, a well-known biomarker for multiple myeloma, using Rapid Novor’s proprietary MS-based protein sequencing technology. EasyM™ can improve the way the disease is monitored to foster informed decisions on potential therapies and treatment regimens. Data from retrospective clinical studies suggest that EasyM™ could provide earlier predictions of relapse compared to conventional methods.

The CLIA certification of Rapid Novor’s Diagnostic Laboratory means that patients in the US diagnosed with multiple myeloma will now be able to access EasyM™ as a clinical testing option for enhanced disease monitoring. Rapid Novor is currently in the process of obtaining certification of the EasyM™ assay within Canada to bring this non-invasive, sensitive, clinical test to Canadian patients with multiple myeloma.

About Rapid Novor Diagnostic Laboratory

Rapid Novor Diagnostic Laboratory is a business unit of Rapid Novor Inc.

For more information, please visit http://www.easym.com.About Rapid Novor Inc.

Rapid Novor Inc., is the world’s leader in antibody protein sequencing technology. Specializing in the field of mass spectrometry-based proteomics, the team has developed the technology to directly sequence antibody proteins without needing access to the producing cell line. Located at the Kitchener-Waterloo high-tech hub, the company continues to build its technology portfolios based on years of scientific research and inventions. The company’s mission is to elevate human health by decoding immunity. For more information, please visit http://www.rapidnovor.com. Follow the company on Twitter @rapidnovor or LinkedIn.

Share article on social media or email:



All Ways Caring HomeCare Partners with Soldiers’ Angels to Support Caregivers Through ‘Women of Valor’ Program


Soldiers' Angels and All Ways Caring

Partnership to benefit caregivers of Post-9/11 wounded, ill, injured Service Members and Veterans

All Ways Caring HomeCare announced today its partnership with the national nonprofit Soldiers’ Angels to support caregivers through its “Women of Valor” program.

All Ways Caring HomeCare announced today its partnership with the national nonprofit Soldiers’ Angels to support caregivers through its “Women of Valor” program. Focusing on female caregivers of post-9/11 wounded, ill and injured Service Members and Veterans, the San Antonio-based non-profit provides Women of Valor caregivers with encouragement through personalized cards, letters, and care packages, as well as services to address the many challenges caregivers face while supporting their loved ones.

“We are thrilled that All Ways Caring is providing us the opportunity to bring these much-needed services to our caregivers free of charge,” said Amy Palmer, Soldiers’ Angels President and CEO. “With the challenges that caregivers face on a daily basis, we hope the love and encouragement offered through this comprehensive program and by their Angel provides them with a little bit of strength and inspiration.”

“We honor our country’s Veterans by delivering the high-quality care and services they need to maintain their independence and dignity in the place they call home,” said Lisa King, All Ways Caring HomeCare Regional Vice President. “Our partnership with Soldiers’ Angels is another way we demonstrate our commitment to current and former members of the armed forces.”

Support services provided to Women of Valor caregivers include: telemedicine, telecounseling and telepsychiatry services provided by MDLIVE; virtual groups and activities to help build relationships and enjoy needed self-care time; resource materials written by subject matter experts; a welcome box and quarterly pampering gifts; and the support of volunteer Angels they can call upon throughout their caregiving journey.

Women of Valor caregivers may be the wife, girlfriend, mother or other female relative of the wounded hero. All caregivers are vetted to ensure eligibility and are then approved for the program. To learn more and to register for the program, visit Women of Valor.

###

About Soldiers’ Angels: Soldiers’ Angels is a national 501(c)(3) nonprofit that provides aid, comfort, and resources to the military, veterans, and their families. Founded in 2003 by the family of General George Patton, hundreds of thousands of Soldiers’ Angels “Angel” volunteers assist veterans, wounded and deployed personnel and their families in a variety of unique and effective ways. (Tax ID# 20-0583415). Learn more at soldiersangels.org.

About All Ways Caring HomeCare: All Ways Caring HomeCare delivers quality, compassionate and highly individualized care and support that helps people in need of assistance stay at home – all while maximizing their dignity, privacy and independence. Whether recovering from illness, injury or surgery, living with a chronic disability or dealing with the natural process of aging, services are tailored to meet the individual needs of people of all ages, physical conditions and cognitive abilities. All Ways Caring HomeCare services include personal care and homemaking programs, professional nursing, geriatric care management, Alzheimer’s/dementia care, respite care and other programs. For more information, please visit AllWaysCaring.com/SoldiersAngels. Follow us on Facebook and LinkedIn

Share article on social media or email:

Catalent and Bhami Research Laboratory Enter into Licensing Agreement for Technology to Deliver High-Concentration Biologics Subcutaneously


The potential for maintaining the stability of a drug with the convenience of a pre-filled syringe or auto-injector could have a significant impact on reducing the barriers to subcutaneous delivery of therapies and improving the patient experience.

Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, and Bhami Research Laboratory (BRL), today announced a licensing agreement that will provide Catalent with access to BRL’s formulation technology to help enable the subcutaneous delivery of high-concentration biologic therapies.

Under the terms of the agreement, financial details of which have not been disclosed, Catalent is authorized to collaborate with its customers to evaluate BRL’s formulation technology to reduce viscosity and deliver high-concentration biologic products. The technology is applicable to a wide range of monoclonal antibodies and fusion proteins, and successful programs could be integrated into Catalent’s formulation and manufacturing services at scale. Small volume and low viscosity biotherapeutics delivered subcutaneously provide superior patient benefits over traditional intravenous injections including improved access to healthcare, reduced need for hospitalization and overall treatment cost, and the opportunity to employ new delivery technologies such as auto-injectors.

“We are delighted to be expanding the reach of our exciting subcutaneous protein delivery platform to customers through this collaboration with Catalent, a global CDMO of repute,” said Dr. Surya Pai, Co-founder and Chief Executive Officer of BRL. Dr. Bhami Shenoy, Co-founder and Chief Scientific Officer of BRL added, “The patented, high-concentration, low-viscosity protein drug delivery platform has been designed to make patient care convenient, affordable and safe.”

“This agreement allows Catalent Biologics to offer its customers a novel patented formulation that may be evaluated for enabling the delivery of high-concentration therapies by reducing viscosity,” said Julien Meissonnier, Catalent’s Chief Scientific Officer. “The potential for maintaining the stability of a drug with the convenience of a pre-filled syringe or auto-injector could have a significant impact on reducing the barriers to subcutaneous delivery of therapies and improving the patient experience.”

About Bhami Research Laboratory

Bhami Research Laboratory Pvt. Ltd. (BRL) is an eight-year-old biotech based out of India, with core expertise in protein and peptide drug delivery. BRL aims to enhance the delivery of biologics therapeutics through its proprietary high concentration subcutaneous protein delivery technology. Additionally, BRL also focuses on oral delivery of peptides through its novel proprietary technology. For more information, http://www.bhamilab.com.

About Catalent Biologics 

For nearly three decades, Catalent Biologics has built capabilities and expertise in development, manufacturing, and analytical services, now spanning new biological entities, biosimilars, plasmid DNA, cell and gene therapies, vaccines, sterile injectables, mRNA, and antibody-drug conjugates. It has developed 600+ antibodies and 80+ recombinant proteins, with more than 120 active clinical trials and 16 marketed biotherapeutics use GPEx® cell line engineering technology. More than 45 commercially approved products have employed Catalent Biologics’ manufacturing and packaging capabilities.

Using advanced technologies and tailored solutions from clinical to commercial supply, Catalent brings better biologic and advanced treatments to patients, faster.

About Catalent

Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs.

Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply around 80 billion doses of nearly 8,000 products annually. Catalent’s expert workforce of approximately 18,000 includes more than 3,000 scientists and technicians.

Headquartered in Somerset, New Jersey, the company generated nearly $5 billion in revenue in its 2022 fiscal year. For more information, http://www.catalent.com

Share article on social media or email:

Labroots Announces Agenda for its 7th Annual Laboratory Automation Virtual Event on March 22, 2023


Laboratory Automation, March 22, 2023

Labroots, the leading scientific social networking website, offering premier, interactive virtual events and webinars, is delighted to host its 7th annual Laboratory Automation event on March 22, 2023. This free online event brings together thousands of research scholars, laboratory managers, scientists, and experts from leading academic and industry institutions globally to explore disciplines with emerging topics ranging from microfluidics: current and upcoming technologies, automation and new methods to achieve it, and compliance with laboratory software, LIMS and automation, and cyber security.

The informative agenda comprises over a dozen presentations discussing the latest advancements regarding instrumentation and methodologies used to increase the efficiency and effectiveness of research in the lab. Participants will learn from renowned speakers sharing their direct insights on cost-effective automation of common ELISA assays, how and informatics tool, such as a LIMS, can help secure sensitive data and prevent cyberattacks, the role of a LIMS in a quality management system, microfluidics in single cell applications, microfluidics platforms for high throughput in vivo screening, the advantages and disadvantages of the SIFT technology, optimize your PCR, and much more.

Conference highlights span keynote and sponsored talks (not limited to):

  • A lively Q&A session, following the presentation sponsored by GenScript, titled, “Automated Tolls to Achieve Consistency, Reliability and Efficiency for Plasmid and Protein Purification, Western Blotting, and Cell Isolation.”
  • Panel Presentation sponsored by Thermo Fisher Scientific on Enzymes for Advancing Point of Care Diagnostics and the best enzymes and products for PCR-and isothermal-based assays.
  • Panel Presentation sponsored by eLabNext on Lab Automation – Taking Lab Digitization to the Next Level, with live Q&A.
  • Panel Presentation sponsored by Opentrons exploring Lab Automation and Community Tools to Support Global Science, with live Q&A.
  • Two keynote deliveries with lively Q&A sessions from these stellar presenters: Dino Di Carlo, PhD, Professor of Bioengineering at UCLA, discussing the importance of probing cellular functions, such as single-cell secretions, and Benjamin Yellen, PhD, Co-Founder, CEO at Celldom exploring live single cell biology at ultra-high throughput for applications in T Cell potency and small molecule drug testing.


“We have developed a powerful new tool in our lab-on-a-particle technology that allows us to capture cells and analyze their secretions in unprecedented detail,” said Dino Di Carlo, Professor of Bioengineering at UCLA. “With our 3D-shaped hydrogel microparticle platforms, we can sort cells based on their secreted products and use this information to discover new antibodies, develop cell lines, and select functional cells for therapies. Our secretion encoded single-cell sequencing (SEC-seq) workflow links the transcriptomes of single cells to their secreted products, enabling us to uncover gene networks associated with high secretion of immunoglobulin G and other key factors. With this technology, we have characterized a unique transcriptionally-defined cluster of mesenchymal stromal cells (MSCs) that secrete higher levels of vascular endothelial growth factor (VEGF), a pro-regenerative growth factor that is thought to drive therapeutic benefit in MSC-based therapeutics. I am excited to share our latest results along with other thought-leaders speaking on Labroots’ platform and discuss the potential for nanovial technology to revolutionize the field of cell therapies,” concluded Di Carlo.

“Techniques for measuring live single cells are essential for surveying the functional diversity cell populations. However, to date it is been challenging to perform time lapse measurements on millions of single cells over the course of many days, which is necessary to find drug resistant cells or to quantify the potency of adoptive T cells against a target antigen,” said Ben Yellen, CEO of Celldom. “In this talk, I will discuss how we have approached this problem by combining microwell technology with high throughput imaging, deep learning-based video classification, and clone retrieval, with the goal of providing a universal platform for future discovery tools and QC workflows for applications in the emerging space of cell and gene therapies.”

Produced on Labroots’ robust platform while connecting across all desktop and mobile devices, the online event encompasses a lobby equipped with a leaderboard and gamification feature, an auditorium hosting live-streaming video webcasts with live attendee chats during scheduled presentations, an exhibit hall highlighting recent contributions and connections in real-time with booth representatives, a poster hall to explore data and engage in live chats with poster authors coupled with a poster competition giving your research a competitive edge, and a networking lounge to encourage collaborations with colleagues.

Labroots is an approved provider of continuing education programs in the clinical laboratory sciences by the ASCLS P. A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education Credit per presentation for a maximum of 30 credits.

To register for the event, click here. Participants can use the official hashtag #LRlabauto to follow the conversation and connect with other members of the Laboratory Automation community! Follow @CellBiology_LR on Twitter and @CellandMolecularBiology.LR on Facebook to connect with our specialist Cell & Molecular Biology Writers and stay up to date with the latest Trending Science News.

About Labroots

Labroots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars, and more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Founded in 2008, Labroots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events. Labroots offers more than ever with Chati, a flexible, highly scalable event platform that allows for the creation of unique, effective, and memorable virtual events.

Share article on social media or email:

Jack & Annie’s Impact Report Evaluates the Brand’s Contributions in Supporting Regenerative Agriculture


News Image

Jack & Annie’s first Lifecycle Assessment Report Shows the jackfruit-based meat alternative company’s sustainability initiatives outperform those of traditional meat products.

“We discovered that jackfruit as an input is 94% better than beef, 60% better than chicken and 87% better than pork for Global Warming Potential.” – Annie Ryu, CEO and Founder, Jack & Annie’s

Jack & Annie’s, a leader in the alternative meat category, knows that fulfilling their mission of making a positive impact in the world includes measuring their own. With their first-ever Impact Report, Jack & Annie’s evaluates the company’s contributions in supporting regenerative agriculture through jackfruit, as well as its efforts to build community in the U.S. and India, support farming family partners, and further understand and improve the company’s own carbon footprint.

“We have always known that our environmental impact is strong. Jackfruit is one of the most sustainable crops, and we continue to partner with our farmers on regenerative practices,” said Annie Ryu, CEO and founder of Jack & Annie’s. “This past year, we took it one step further, performing our first LCA (Life Cycle Assessment). We discovered that jackfruit as an input is 94% better than beef, 60% better than chicken and 87% better than pork for Global Warming Potential.”

Jack & Annie’s is a global company, with teams in India and the U.S. working together to make a positive impact. In the U.S., the team participates in community programs to lessen food waste and is committed to Diversity, Equity and Inclusion. Additionally, Jack & Annie’s is proud to partner with over 1,700 farming families in India, who help harvest the jackfruit. The farmers benefit by being educated about the value of jackfruit on their land; selling jackfruit to Jack & Annie’s enables farmers to increase their income by 10-40%. Additionally, by building these relationships over the past decade, Jack & Annie’s has been able to study and calculate the carbon sequestration of the jackfruit trees, which equates to 28,000 metric tons of CO2 per year.

“The novel supply chains we’ve built have helped create a food system that offers both a healthy diet and a lower carbon footprint and provides an opportunity for small-holder farmers to earn incremental income. At scale, this food system will play an important role in solving this century’s critical problems – public health, climate change and economic empowerment,” says Rahul Shrikant, Jack & Annie’s VP of International Operations.

Jack & Annie’s plans to further quantify its impact on food, farmers and the environment by planting 50,000 jackfruit trees per year to sequester more carbon. The company will also continue to provide education and assistance to farmers, bolster diversity through unconscious bias training, perform an ESG Materiality Assessment, and begin to take inventory of their carbon emissions.

ABOUT JACK & ANNIE’S

Jack & Annie’s, made by The Jackfruit Company and founded by Annie Ryu, is on a mission to create real, delicious foods that feature jackfruit, an underutilized crop that is one of the world’s most sustainable and regenerative plants, as the primary ingredient. Jack & Annie’s plant-based offerings are more than just a delicious alternative to meat, they are also naturally nutrient-dense, high in fiber and protein, and lower in calories, and have a simpler ingredient panel than other meatless products. From crispy jack nuggets to savory jack sausage patties, the Jack & Annie’s portfolio offers foods that are satisfying for meat eaters and plant-based eaters alike. Bite-by-bite, Jack & Annie’s and The Jackfruit Company are building a better planet, supporting farming communities in India by preventing jackfruit from going to waste, operating the largest global jackfruit supply chain, and providing over 1,700 farming families with 10-40% of their income.

To view the full report, please visit jackandannies.com/impact/impact-report/.

For more information about Jack & Annie’s, please visit jackandannies.com or follow on Instagram @jackandannies, Twitter @jackandannies and Facebook @jackandannies.

# # #

Share article on social media or email:



Refocus Recovery Becomes Official 501(c)3 Nonprofit, Providing Expansion Opportunity For Their Free Certified Peer Recovery Specialist Training


News Image

“Becoming a nonprofit organization allows us to expand our free Certified Peer Recovery Specialist training to those who need it; we’ve already trained over 500 people in the last 12 months and look forward to seeing that number grow.”

Refocus Recovery, a grassroots organization that believes in the power of peer-to-peer relationships to break down barriers to sustained recovery from Substance Use Disorder, today announced that it has become a 501(c)3 nonprofit. The new status allows Refocus Recovery to continue removing barriers to accessing peer services by expanding their free Certified Peer Recovery Specialist training and building upon their already extensive network of compassionate community resources.

“Minnesotans are in crisis and the demand for Substance Use Disorder treatment continues to rise,” said Refocus Recovery Executive Director, Tim Sanders. “Becoming a nonprofit organization allows us to expand our free Certified Peer Recovery Specialist training to those who need it; we’ve already trained over 500 people in the last 12 months and look forward to seeing that number grow.”

Unlike many other Substance Use Disorder recovery organizations, Refocus Recovery does not only focus on how they alone can deliver recovery services. Instead, they believe in the power of building networks and collaboration by partnering with countless organizations to create a flexible workforce that is capable of providing services to as many individuals as possible. While Refocus Recovery seeks to remove all barriers to sustained recovery, they are especially focused on:

  • Developing job skills and financial orientation
  • Securing housing opportunities
  • Support with legal issues
  • Providing family and community advocacy
  • Securing basic transportation

“This new status gives us the opportunity to reach more people than ever before and provide them with essential resources that will help them get back on track,” said Refocus Recovery Managing Director, Matt McLane. “We are dedicated to helping individuals find sustainable paths towards recovery so they can lead healthier lives.”

As an official 501(c)3 non-profit organization, Refocus Recovery will continue empowering individuals seeking recovery from Substance Use Disorder through their unique approach of leveraging networks and collaboration within communities across Minnesota. This status also allows Refocus Recovery to offer fiscal sponsorship for other Recovery Community Organizations who wish to start or expand their own peer recovery services.

About Refocus Recovery

Refocus Recovery is a grassroots organization that fosters peer to peer relationships within the multiple pathways to recovery. Refocus Recovery’s program focuses on developing and supporting a pathway to recovery for those affected by substance use, offering Peer Recovery Specialists who serve as mentors, advocates, and community networkers. The organization’s mission is to support, empower, and guide people in the recovery community toward reaching their recovery goals through personal connection and shared experiences. For more information, visit https://www.refocusrecovery.org/.

Share article on social media or email:

KnowBe4 Launches Phishing Security Resource Kit To Help Combat the Most Common Form of Social Engineering


KnowBe4’s phishing security resource kit will include user resources such as access to a free on-demand webinar on phishing mitigation, KnowBe4’s most popular phishing white paper, “Comprehensive Anti-Phishing Guide E-Book” and more.

KnowBe4, the provider of the world’s largest security awareness training and simulated phishing platform, today announced the release of its phishing security resource kit to help end users defend themselves and their organizations against the threat of phishing attacks.

Phishing is a social engineering scheme in which bad actors attempt to acquire sensitive information from users such as login credentials and credit card information or trick them into clicking on an infected link or attachment that can download malware by disguising the email as being from a trustworthy entity like a known contact or organization. Over 90% of successful data breaches and hacks start with phishing scams — it is the most common form of social engineering and a threat to every end user and organization around the world.

KnowBe4’s phishing security resource kit will include user resources such as access to a free on-demand webinar on phishing mitigation, KnowBe4’s most popular phishing white paper, “Comprehensive Anti-Phishing Guide E-Book”, a video on how to avoid phishing attacks, infographics, posters, digital signage and more.

“Phishing remains one of the most dangerous threats to users and organizations because of how easily it can be disguised and its potential to cause detrimental harm and fallout,” said Stu Sjouwerman, CEO, KnowBe4. “KnowBe4 recognizes the significance of this threat, which is why we are dedicated to producing world-class, new-school security awareness training and resources to educate users on the signs of phishing scams and how to best prepare and defend against them. Our new phishing security resource kit enables end users and organizations to strengthen their security culture and make smarter security decisions.”

To download the KnowBe4 Phishing Security Resource Kit, visit https://www.knowbe4.com/phishing-resource-kit.

About KnowBe4

KnowBe4, the provider of the world’s largest security awareness training and simulated phishing platform, is used by more than 56,000 organizations around the globe. Founded by IT and data security specialist Stu Sjouwerman, KnowBe4 helps organizations address the human element of security by raising awareness about ransomware, CEO fraud, and other social engineering tactics through a new-school approach to awareness training on security. Kevin Mitnick, an internationally recognized cybersecurity specialist, and KnowBe4’s Chief Hacking Officer, helped design the KnowBe4 training based on his well-documented social engineering tactics. Tens of thousands of organizations rely on KnowBe4 to mobilize their end users as their last line of defense.

Share article on social media or email:

rAAV Manufacturing — Enzymatic DNA for Achieving a Robust & High-Quality DNA Supply, Upcoming Webinar Hosted by Xtalks


The manufacture of rAAV continues to be challenged to incorporate faster, safer, scalable and cheaper critical starting material and manufacturing processes to meet timelines and regulatory demands.

The gene therapy clinical pipeline continues to be in a growth phase, with over 2,000 therapies in development globally, with recombinant adeno-associated viral vectors (rAAV) as one of the most powerful tools for gene delivery to treat human disease, leading the way.

The manufacture of rAAV continues to be challenged to incorporate faster, safer, scalable and cheaper critical starting material and manufacturing processes to meet timelines and regulatory demands. dbDNA™1 (Doggybone™), a novel enzymatic DNA technology, is a good critical starting material for rAAV production that can support the demands in the rapidly evolving gene therapy field and addresses the current challenges faced in rAAV manufacture.

In this webinar, the featured speakers will present the TAAV-manufactured enzymatic DNA process and product, featuring the advantages of the technology, such as regulatory benefits of using a bacterial-free DNA vector, leading to a more efficient and robust production. The speakers will discuss the quality control and assurance system that enables TAAV to provide a high quality product that can support an efficient rAAV manufacturing process throughout all phases of development from preclinical to clinical.

Join the featured experts to learn more about achieving a robust, scalable and high-quality DNA supply in recombinant adeno-associated viral vector gene therapy manufacturing.

1 dbDNA™ technology is licensed from Touchlight UK.

Join experts from TAAV Biomanufacturing Solutions, Dr. Leticia Agúndez, R&D Senior Manager; and Lucía San Miguel, Quality Senior Manager, for the live webinar on Tuesday, March 28, 2023, at 3pm EDT (12pm PDT).

For more information, or to register for this event, visit rAAV Manufacturing — Enzymatic DNA for Achieving a Robust & High-Quality DNA Supply.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

The Undefeated Tribe, a Crunch Fitness Franchise, Partners with Lamar Outdoor


The Undefeated Tribe, a Crunch Fitness franchise, today announced a partnership with Lamar Outdoor, a marketing agency focused on market penetration. This move comes on the heels of the Undefeated Tribe’s recent growth in Texas and Oklahoma. The partnership will lead to 50+ locations, adding to their current portfolio of 12 Crunch Fitness clubs.

Lamar Outdoor is the Undefeated Tribe’s preferred partner for billboard purchasing and placement. They are exceptional marketing partners of and help ensure the brand is proudly displayed throughout existing and new markets.

“The professional executives at Lamar have partnered with us from day one to gain brand awareness and build equity in our new markets. We will continue building new gyms and utilizing our partnership with Lamar to showcase Crunch’s competitive advantages and to build a community around our brand,” Hartl said.

Crunch Fitness locations offer top-quality cardio equipment and strength training equipment, circuit training, a functional training area with an indoor turf area, a dedicated group fitness studio, a dedicated Ride indoor cycling studio, HydroMassage® beds, saunas, and high-end tanning. Members looking for assistance reaching their goals will have access to highly experienced Personal Trainers.

As the franchise continues to grow, The Undefeated Tribe will be inviting hundreds of individuals to join their team to help communities across Texas and Oklahoma experience fitness, wellness, relaxation and recovery.

If you are interested in Working Hard, Having Fun and Making History please apply today at epiccrunchjobs.com.

About The Undefeated Tribe

Founded in 2018 by Tony Hartl, The Undefeated Tribe is one of the fastest growing franchises within the Crunch Fitness system. The Company currently operates locations in Texas and Oklahoma, with many more in development. In 2021 The Undefeated Tribe was selected as the Franchise of the Year for the Crunch Fitness system. The Undefeated Tribe was recognized as the top-performing franchise for its unique accomplishments and excellence in business performance, community service, and brand involvement.

Share article on social media or email:

Sensate Raises $3.2M Seed Round to Reduce the Effects of Stress and Expand Access to Wellness


Lower stress and anxiety with Sensate

“Millions of people are seeking an easy way to feel less stressed and anxious and we’ve seenincreasing demand for our product. In the second half of 2022, we grew almost 300% and thisround will allow us to scale and serve even more people,” said Anna Gudmundson,Co-Founder and CEO of Sensate.

Sensate, a wellness technology company that created a patented relaxation device+app turning the tide on stress, announced today that it closed $3.2M in a seed funding round in February, led by Incisive Ventures.

Co-investors in the round include Share Ventures, Geek Ventures, Dangerous Ventures, Unlock Venture Partners, What If Ventures, Moai Capital and 37 Angels.

Sensate’s hardware and subscription app innovation uses patented technology designed to activate the body’s natural ability to self-regulate. An incredibly easy, fast, and accessible way to relieve stress, the device was developed by physicians and tested in clinics. Using infrasonic therapy to help the body’s nervous system recover from daily stresses, Sensate’s intelligent touch therapy is entirely effort-free for the user.

A portion of the seed round was raised via Wefunder, the leading retail investment platform for Regulation Crowdfunding. Through Wefunder, the company offered over 900 customers, early supporters and friends, including Hollywood celebrities, the chance to become shareholders in Sensate alongside institutional investors in a seed round via an SPV.

“Millions of people are seeking an easy way to feel less stressed and anxious and we’ve seen increasing demand for our product. In the second half of 2022, we grew almost 300% and this round will allow us to scale and serve even more people,” said Anna Gudmundson, Co-Founder and CEO of Sensate.

Gudmundson’s Co-founder is Sensate innovator and integrated medicine physician, Stefan Chmelik. Chmelik has decades of clinical experience specializing in complex stress and health issues. Gudmundson herself has over 15 years of experience in exponential technologies, and as in previous roles like turnaround CEO, she effectively optimizes and delivers company product, brand and business strategy.

“We’ve been looking for a team and platform focused on the opportunity to explore vagus nerve toning,” stated Hamet Watt, Founder and Managing Partner at Share Ventures, a Los Angeles-based venture foundry and fund. “We’re excited to have found that in Sensate, and are thrilled to support their innovative wellness technology, which has the potential to revolutionize the way people manage stress and anxiety. Sensate’s management and team both bring unique expertise to this field, and we look forward to partnering with them on their mission to promote mental wellness.”

Geek Ventures, an NYC-based VC that invests in immigrant founders building exciting scalable tech, also invested in the round. Ihar Mahaniok, Managing Partner at Geek, added,

“I’ve seen firsthand the transformative power of Sensate’s device, and it’s clear that I’m not the only one. The love and loyalty from their users are a testament to the incredible impact they are having on people’s lives. With such a talented team at the helm, I have no doubt that Sensate will continue to innovate and build solutions that make a real difference in the world, and I am glad we can support them in their quest.”

Sensate’s breakthrough technology has been dubbed ‘a genius device’ by Forbes and was honored as a TIME Magazine Best Invention of 2022. Sensate exceeded its 2022 growth targets, with a $10.2M revenue run rate as of December 2022. Sensate is poised to combat the global stress crisis, revolutionizing the exponentially growing $4.2T wellness market.

Companies or Investor Relations firms interested in learning more about Sensate and its mission can visit https://www.getsensate.com/.

About Sensate

Sensate, Inc. is a wellness technology company with a mission to bring stress resilience and well-being to people from all walks of life. Using powerful methods and groundbreaking technology, the company offers patented stress-regulation hardware and software applications for the consumer market. Sensate is a direct-to-consumer business selling globally, with operations in the US and UK. Sensate can be found on http://www.getsensate.com as well as in world-class retailers, including Harrods, Selfridges, Amazon, and has been featured in TIME, Forbes, Vogue, Buzzfeed, BBC Click, Mashable, CNBC and many more.

Share article on social media or email: